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[F(11) = 5.01, P < 0.047] of salivary lysozyme, with this 
being higher in N at every time-point.
Conclusion Whether the observed differences between H 
and N are of sufficient magnitude to clinically impair host 
defence is questionable, particularly as they are transient in 
nature and since other immune markers are unaffected. As 
such, acute hypoxic exercise likely does not pose a mean-
ingful additional threat to immune function compared to 
exercise at sea level, provided that absolute workload is 
reduced in hypoxia so that relative exercise intensity is the 
same.
Keywords Altitude · Endurance · Cortisol · S-IgA · 
Cytokine · Lymphocytes
Introduction
Various forms of hypoxic training are used by competitive 
endurance athletes, both to acclimatise before competition 
at altitude (Fulco et al. 2000) and to improve exercise per-
formance at sea level (Levine and Stray-Gundersen 1997; 
Stray-Gundersen et al. 2001). Exercise in hypoxic condi-
tions typically causes greater physiological stress than 
exercise at sea level (Bailey and Davies 1997). Taking into 
account this augmented stress response to exercise, coupled 
with reports of increased resting levels of adrenaline, corti-
sol and interleukin-6 at high altitude (Mazzeo et al. 2001), 
it seems reasonable to hypothesise that hypoxic training 
might pose a greater threat to immune function compared 
to equivalent training at sea level. Indeed, both anecdotal 
evidence from athletes and coaches, and scientific literature 
point towards an increased incidence of opportunistic infec-
tious illness during and immediately after altitude training 
(Bailey et al. 1998; Gore et al. 1998). This may be due, at 
Abstract 
Purpose To determine how immune markers are affected 
by acute hypoxic exercise at the same relative intensity.
Methods Twelve endurance-trained males (age: 
28 ± 4 years, V˙O2max: 63.7 ± 5.3 mL/kg/min) cycled for 
75 min at 70 % of altitude-specific V˙O2max, once in nor-
moxia (N) and once in hypobaric hypoxia equivalent to 
2000 m above sea-level (H). Blood and saliva samples were 
collected pre-, post- and 2 h post-exercise.
Results Participants cycled at 10.5 % lower power out-
put in H vs. N, with no significant differences in heart rate 
(P = 0.10) or rating of perceived exertion (P = 0.21). Post-
exercise plasma cortisol was higher in H vs. N [683 (95 % 
CI 576–810) nmol/l vs. 549 (469–643) nmol/l, P = 0.017]. 
The exercise-induced decrease in CD4:CD8 ratio was 
greater in H vs. N (−0.5 ± 0.2 vs. −0.3 ± 0.2, P = 0.019). 
There were no significant between-trial differences for 
adrenocorticotropic hormone, plasma cytokines, antigen-
stimulated cytokine production, salivary immunoglobulin-
A or lactoferrin. However, there was a main trial effect 
for concentration [F(11) = 5.99, P < 0.032] and secretion 
Communicated by Fabio Fischetti.
This manuscript has been read and approved by all the listed 
co-authors. This manuscript is original and neither previously 
published, nor it is being considered elsewhere until a decision is 
made as to its acceptability by the EJAP Editorial Review Board.
 * Ida S. Svendsen 
 i.s.svendsen@lboro.ac.uk
1 School of Sport, Exercise and Health Sciences, 
Loughborough University, Loughborough LE11 3TU, UK
2 Norwegian Olympic and Paralympic Committee 
and Confederation of Sports, Oslo, Norway
1220 Eur J Appl Physiol (2016) 116:1219–1229
1 3
least in part, to an impairment of T cell-mediated immunity 
during altitude exposure (Meehan et al. 1988; Facco et al. 
2005; Oliver et al. 2013; Pyne et al. 2000). Meanwhile, 
other aspects of immunity do not appear to respond nega-
tively to hypoxic training. Tiollier et al. (2005) found that 
salivary secretory immunoglobulin-A (S-IgA) decreased 
progressively in elite cross-country skiers training at 1200 
m above sea-level (masl). However, this decrease was not 
exacerbated in athletes sleeping at 2500–3500 masl com-
pared to the control group who slept at 1200 masl, and 
Born et al. (2015) actually observed increases in both 
salivary S-IgA and alpha-amylase following intermittent 
hypoxic training. Natural killer cell activity (Klokker et al. 
1995; Wang and Wu 2009) and B-cell function (Pyne et al. 
2000) appear to be unaffected or increased by hypoxic 
training, as does neutrophil function (Wang and Chiu 2009; 
Chouker et al. 2005). Nevertheless, it is still unclear how 
many aspects of immune function respond to hypoxic 
exercise, and particularly to the types of exercise and lev-
els of hypoxia that athletes are typically exposed to during 
training or competition at altitude. Furthermore, it is well 
known that maximal oxygen uptake (V˙O2max) is reduced 
at altitude, with the magnitude of this reduction being 
proportional to the level of hypoxia (Ferretti et al. 1997). 
Some previous studies that have investigated differences in 
immune responses to an acute bout of exercise performed 
in normoxic and hypoxic conditions have matched trials 
based on absolute workload, such as a specific running 
speed or power output (Klokker et al. 1995; Mazzeo et al. 
2001). However, because of the reduction in V˙O2max, the 
same absolute workload performed in hypoxia will result 
in higher relative exercise intensity (% V˙O2max). To deter-
mine whether the differences in responses observed are due 
to hypoxia per-se, rather than this increase in relative exer-
cise intensity, it is useful to instead match trials based on a 
fraction of altitude-specific V˙O2max. This is also of greater 
relevance to endurance athlete populations, since they will 
typically train at a similar, or even a lower, relative exer-
cise intensity at altitude as when they are at sea level (Gore 
et al. 1998).
Traditional forms of hypoxic training involve prolonged 
sojourns at natural altitude. Today, however, an increasing 
number of athletes utilise “live low, train high” protocols, 
during which only a proportion of training sessions are per-
formed in acute hypoxia. Although the efficacy of this type 
of hypoxic training in improving sea-level performance 
remains somewhat equivocal (McLean et al. 2014) it has 
become popular due to being more cost-effective and con-
venient than traveling to natural altitude. Nevertheless, it is 
not yet understood how many aspects of the immune sys-
tem respond to this type of hypoxic training. The aim of 
the current study was therefore to determine how markers 
of systemic and mucosal immunity are affected by an acute 
bout of endurance exercise in hypobaric hypoxia equiva-




Twelve endurance-trained males volunteered their writ-
ten, informed consent to take part in the study [mean 
(± SD) age: 28 ± 4 years, body mass 79.1 ± 5.9 kg, V˙
O2max 63.7 ± 5.3 mL/kg/min, 5.06 ± 0.45 L/min], which 
was approved by the regional ethics committee of south-
ern Norway. Before the start of the study, participants 
completed a health-screening questionnaire. Participants 
could be included if they were between 18 and 40 years of 
age, participating in regular endurance training, currently 
healthy and without URS or use of any medication during 
the past 4 weeks. Exclusion criteria were smoking, suffer-
ing from, or with a history of, cardiac, hepatic, pulmonary, 
renal, neurological, haematological, psychiatric, or gastro-
intestinal illness, or exposure to natural or simulated alti-
tude (equivalent to ≥1000 m above sea level) during the 
past 8 weeks.
Laboratory visits
On the first laboratory visit, 1–2 weeks before the first 
experimental trial, participants completed a continuous, 
incremental exercise test to volitional exhaustion in nor-
mobaric conditions on an electromagnetically braked cycle 
ergometer (Lode Excalibur Sport, Groningen, The Nether-
lands) for determination of V˙2max. The test began at 60 W 
with increments of 35 W every 3 min. Rating of perceived 
exertion (RPE) was noted during the final minute of each 
stage and heart rate measured continuously using short-
range telemetry (Polar, Kempele, Finland). Expired gas 
was collected and analysed continuously using a comput-
erized metabolic system with mixing chamber (Oxycon 
Pro, Erich Jaeger GmbH, Hoechberg, Germany) for deter-
mination of minute ventilation, oxygen uptake and carbon 
dioxide production. The gas analysers were calibrated with 
certified calibration gases of known concentrations before 
every test. The flow turbine was calibrated before every 
test with a 3 L calibration syringe (CareFusion, Hoech-
berg, Germany). The work rate corresponding to 70 % V˙
O2max was then calculated from the V˙O2-work rate relation-
ship using a linear equation. The same relative workload 
for the hypoxic trial was calculated based on data from a 
previous study conducted in the decompression chamber 
showing that, for individuals of this training status, V˙O2max 
decreases by approximately 10.4 % from 59.8 ± 7.4 to 
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53.6 ± 6.7 ml/kg/min in hypobaric hypoxia equivalent to 
2000 masl (Hårklau 2011), a finding supported by earlier 
studies that have similarly observed a reduction of ~10 % 
(Eriksen 2002; Sylta 2009). As such, the following formula 
was used to predict V˙O2max at 2000 masl:
The same linear regression equation used to calculate 
workload in normoxia was then applied to determine the 
workload corresponding to 70 % of the predicted V˙O2max 
at 2000 masl.
For both main experimental trials, participants arrived at 
the laboratory at 07:45 am following an overnight fast of at 
least 10 h, and having abstained from caffeine for a mini-
mum of 12 h. Participants were also required to abstain 
from alcohol and strenuous exercise for at least 24 h before 
each trial and, in an effort to standardize nutritional status, 
asked to record and replicate their dietary intake the day 
before. For both trials, participants completed a standard-
ised 10 min warm-up at 55 % of altitude specific V˙O2max, 
followed by 75 min at 70 % altitude specific V˙O2max, on 
an electromagnetically braked cycle ergometer (Lode 
Excalibur Sport, Groningen, Netherlands) inside a decom-
pression chamber (Norsk undervannsteknikk A/S, Haug-
esund, Norway). Following the exercise bout, participants 
remained inside the decompression chamber for a 2 h rest-
ing recovery. During the normoxic trial (N), the decom-
pression chamber was switched off, and the doors remained 
open. For the hypoxic trial (H), the pressure was adjusted 
to 800 mbar (equivalent to 2000 masl at 17 °C). Oxygen 
and carbon dioxide levels inside the chamber were con-
tinuously monitored throughout the trials. Carbon dioxide 
levels were maintained via three CO2 scrubbers containing 
soda lime, and oxygen was supplied continuously at a rate 
equal to oxygen consumption to preserve normal ambient 
composition (~20.9 % O2, ~0.04 % CO2). To confirm that 
the same relative exercise was achieved in both trials, heart 
rate was measured continuously via short range telemetry 
(RCX3, Polar, Kempele, Finland), RPE was recorded every 
10 min, and blood lactate concentration was measured from 
a finger prick blood sample using a portable blood lactate 
analyser (Lactate Pro LT-1710, Arkray, Kyoto, Japan) every 
20 min during exercise.
Saliva collection
Saliva samples were collected at rest immediately before 
entry into the decompression chamber (PRE), immediately 
after cessation of exercise (POST), and after a 2 h recov-
ery period (2 h POST). After sitting quietly for a few min-
utes, participants were instructed to swallow to empty the 
mouth before collecting unstimulated whole saliva into 
a pre-weighed 7 mL screw-top vial over a predetermined 
Predicted V˙O2max at 2000 masl = 0.896 ∗ V˙O2max at sea level
time period (3–4 min). During the collection time, partici-
pants were instructed to remain seated, leaning forwards 
with their head tilted down, allowing the saliva to dribble 
passively into the collection tube with minimal orofacial 
movement. Saliva volume was determined by weighing to 
the nearest milligram, with saliva density estimated to be 
1.0 g/ml (Cole and Eastoe 2014). Saliva flow rate was then 
calculated by dividing the volume by the collection time. 
Samples were centrifuged for 3 min at 14,000g before 
being stored at −80 °C until analysis.
Blood sampling
Blood samples were collected at the same time points as 
saliva. On each occasion, a venous blood sample (11 mL) 
was obtained by venepuncture from an antecubital vein. 
Blood was collected into two vacutainer tubes (Becton–
Dickinson, Oxford, UK) containing either lithium heparin 
or K3EDTA as anticoagulant.
Plasma cytokines, adrenocorticotropic hormone 
(ACTH) and cortisol
The K3EDTA sample was centrifuged for 10 min at 1500g 
and 4 °C. Plasma was aliquoted and stored at −20 °C 
until analysis. Plasma concentrations of interferon gamma 
(IFN-γ), tumor necrosis factor alpha (TNF-α), interleukin- 
(IL-)1α, IL-6, IL-8, IL-10, epidermal growth factor (EGF), 
vascular endothelial growth factor (VEGF) and monocyte 
chemoattractant protein-1 (MCP-1) were determined with 
an Evidence Investigator System using the cytokine biochip 
array EV 3623 (Randox, County Antrim, UK). The intra-
assay coefficient of variation was <5 % for all measured 
cytokines. Plasma concentrations of cortisol were deter-
mined using a commercially available solid phase com-
petitive enzyme-linked immunosorbent assay (IBL Inter-
national, Hamburg, Germany), with analytical sensitivity 
of 2.46 ng mL−1 and intra-assay coefficient of variation of 
<3.0 %. Plasma concentrations of ACTH were determined 
using a commercially available two-site enzyme-linked 
immunosorbent assay (Biomerica, California), with ana-
lytical sensitivity of 0.22 pg ml−1 and intra-assay coeffi-
cient of variation of <6.0 %. Plates were read on a micro-
titre plate reader at 450 nm. All samples were assayed in 
duplicate.
Antigen‑stimulated cytokine production
Stimulated whole blood culture production of IFN-γ, TNF-
α, IL-1α, IL-1β, IL-2, IL-4, and IL-10 was determined as 
follows: for each sample, 0.25 mL heparinized whole blood 
was added to 0.75 mL RPMI medium (Sigma Chemicals, 
Poole, UK) with added stimulant at a dilution of 1:2000. 
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The dilution used was based on a separate experiment 
(unpublished data), which established the dose–response 
curve for the measured cytokines over the dilution range 
of 1:200–1:20,000. The stimulant used was a commercially 
available multiantigen (DTaP/IPV/Hib) vaccine contain-
ing diphtheria, tetanus, acellular pertussis, poliomyelitis, 
and Haemophilus influenza type b antigens (Pediacel vac-
cine, Sanofi Pasteur, Maidenhead, UK). All participants in 
the current study had received the DTaP/IPV/Hib vaccine 
as infants. The whole blood culture was then incubated 
for 24 h at 37 °C and 5 % CO2. Following centrifugation 
for 4 min at 13,000g in a microcentrifuge, supernatants 
were collected and stored frozen at −20 °C until analysis. 
Cytokine concentrations were determined with an Evidence 
Investigator System using the cytokine biochip array EV 
3623 (Randox, County Antrim, UK). The intra-assay coef-
ficient of variation was <5 % for all measured cytokines.
Salivary antimicrobial proteins Commercially available 
ELISA kits were used to determine salivary concentra-
tions of S-IgA (Salimetrics, Philadelphia, USA) lysozyme 
(Biomedical Technologies, USA) and lactoferrin (Calbio-
chem, Merck KGaA, Darmstadt, Germany). For Lysozyme 
and Lactoferrin, saliva was diluted 500× before analysis. 
Secretion rates for each of the salivary antimicrobial pro-
teins were calculated by multiplying saliva flow rate by 
concentration. All samples were assayed in duplicate. The 
intra-assay CV for S-IgA, lysozyme and lactoferrin were 
1.8, 5.3 and 3.0 %, respectively.
Lymphocyte subsets
For a subset of 8 participants, fluorescent-conjugated 
monoclonal antibodies were used to identify specific 
cell surface markers (CD3, CD8, CD4, CD25, CD127) 
via four colour flow-cytometry with True Volumetric 
Absolute Counting (Partec CyFlow ML, Germany) and 
FloMax analysis software (Quantum Analysis GmbH). 
Briefly, either 10 μL of human regulatory T cell cocktail 
(Becton–Dickinson Biosciences, Oxford, UK) or 10 μL 
of FITC anti-human CD3 + 10 μL PeCy7 CD4 + 10 μL 
PE CD8 (Becton–Dickinson Biosciences) were added to 
120 μL heparinized whole blood and incubated in the 
dark for 20 min on ice. Erythrocytes were then lysed 
by adding 1.5 mL of lyse solution (FACS lysis buffer, 
Becton–Dickinson Biosciences). The sample was subse-
quently incubated for a further 10 min, before centrifuga-
tion at 1500g for 6 min. The supernatant was aspirated 
and the cells re-suspended in phosphate buffered saline 
solution containing 0.1 % bovine serum albumin and 
2 mM EDTA. The mixture was centrifuged for a further 
6 min at 1500g, the supernatant aspirated and the cells 
re-suspended in 1000 μL phosphate buffered saline. 
Forward-scatter versus side-scatter plots were used to 
gate lymphocytes based on size and density, with 50,000 
lymphocyte events acquired per analysis. CD4+ lym-
phocytes were further gated to identify CD25+ cells, 
and those that were also CD127low/-. This was based on 
the finding that CD127 expression inversely correlates 
with FoxP3 (Liu et al. 2006) and can therefore be used 
to identify T regulatory cells. CD3+ cells were further 
gated to identify cells that were CD4+ (T helper) and 
CD8+ (T suppressor). CV for determination of all lym-
phocyte subsets was <6 %.
Statistical analyses
A priori analyses were conducted using G*Power 3 (Faul 
et al. 2007). Based on these data a sample size of 12 was 
predicted to be sufficient to detect statistically significant 
differences between immune responses in normoxia and 
hypoxia, and minimize the type 2 error rate. Data are pre-
sented as mean ± standard deviation (SD) unless other-
wise stated. All statistical analyses were performed using 
IBM SPSS Statistics 22.0. The Shapiro–Wilk test was used 
to determine whether data were normally distributed. A 
two-way repeated measures analysis of variance was used 
to determine whether there were significant differences 
between hypoxic and normoxic trials PRE, POST and 2 h 
POST. A post hoc test with Bonferroni correction for mul-
tiple comparisons was used to determine the location of 
variance. Variables found to be significantly non-normal 
were log transformed before analysis (Box and Cox 1964), 
and are presented as back-transformed geometric mean 
with 95 % confidence interval (CI). Based on the results of 
Mauchly’s sphericity test, Greenhouse-Geisser corrections 
were applied for epsilon <0.75 and Huynd-Feldt correc-
tions applied for epsilon >0.75 where violations of spheric-
ity were identified. Statistical significance was accepted at 
the P < 0.05 level.
Results
On average, participants cycled at 10.5 % lower power out-
put in H compared to N (191 ± 26 vs. 213 ± 30 W). There 
were no significant differences in heart rate, blood lactate 
concentration or RPE between trials (Fig. 1).
Plasma cytokines, ACTH and cortisol
In both trials, plasma cortisol and ACTH (Fig. 2) con-
centrations were significantly lower 2 h post exercise 
compared to pre-exercise and immediately post-exercise. 
Plasma cortisol immediately post-exercise was signifi-
cantly higher in H compared to N 683 (95 % CI 576–
810) nmol/l vs. 549 (469–643) nmol/l, P = 0.017). There 
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were no significant differences between trials at any time 
point for plasma ACTH. Table 1 shows plasma cytokine 
concentrations before, immediately after and 2 h after 
exercise in normoxic and hypoxic conditions. There were 
no significant differences between trials at any time point 
for any of the measured cytokines. However, plasma 
IL-6, IL-8 and MCP1 concentrations were significantly 
elevated post and 2 h post-exercise in both H and N, with 
only IL-6 remaining elevated at 2 h post-exercise. Plasma 
VEGF was significantly reduced immediately post-exer-
cise in both conditions, before returning to baseline 2 h 
post exercise.
Antigen‑stimulated cytokine production
Figures 3 and 4 show in vivo pro-inflammatory and anti-
inflammatory cytokine production in whole blood culture in 
response to a multi-antigen challenge. Production of TNFα, 
IL-1 and IL-4 were significantly reduced 2 h post-exercise. 
There were no significant differences between the two trials.
Salivary antimicrobial proteins
There were no significant differences in S-IgA concen-
tration or secretion rate (Table 2). Both concentration 
and secretion rates of salivary lysozyme (P = 0.005 and 
P = 0.014, respectively) and lactoferrin (P = 0.0009 and 
P = 0.002, respectively) were significantly increased post-
exercise, with lactoferrin remaining significantly elevated 
2 h post-exercise. There was a significant main effect of 
hypoxia for both concentration [F(11) = 5.99, P = 0.032] 
Fig. 1  Average RPE, heart rate and blood lactate concentration during exercise in normoxia and hypoxia. Bars represent group mean, lines rep-
resent individual responses
Fig. 2  Plasma cortisol and ACTH before, immediately after, and 2 h 
after cycling exercise in normoxia and hypoxia. Bars represent group 
mean, lines represent individual responses. *Significant difference 
from normoxia (P < 0.05). #Both trials are significantly different from 
pre-exercise and post-exercise (P < 0.01)
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and secretion rate [F(11) = 5.01, P = 0.047] of salivary 
lysozyme, with this being higher in N at every time-point.
Lymphocyte subsets
Total number of circulating lymphocytes (P = 0.018), T 
cells (CD3+; P = 0.008), T helper cells (CD3+CD4+; 
P = 0.025) and T suppressor cells (CD3+CD8+; 
P = 0.002) were all significantly reduced 2 h post- exer-
cise (Table 3). The relative number of lymphocytes as 
a percentage of total leukocytes was also significantly 
reduced post (P = 0.0013) and 2 h post-exercise in both 
trials (P = 0.0001). There was no change in the absolute or 
relative number of T regulatory cells. The exercise-induced 
decrease in CD4:CD8 ratio was significantly greater in H 
compared to N (−0.5 ± 0.2 vs. −0.3 ± 0.2, P = 0.019), 
ES(d) = 0.6, Fig. 5), but in both trials this returned to base-
line by 2 h post-exercise. There were no significant differ-
ences between conditions for any of the other variables.
Discussion
The main finding of the current study is that, despite a 
somewhat augmented stress response as indicated by higher 
post-exercise plasma cortisol, an acute exercise bout in 
hypobaric hypoxia equivalent to 2000 masl does not appear 
to pose any meaningful additional threat to immune func-
tion compared to exercising at the same relative intensity 
in normoxia. However, previous studies have found that 
hypoxic exercise at the same absolute exercise intensity can 
exacerbate immune disturbances, highlighting the impor-
tance of accurately controlling exercise intensity at altitude. 
Lundy and Steensberg (2004) found that there was no dif-
ference in post-exercise plasma IL-6 concentration with 
either acute or chronic hypoxic exposure when participants 
cycled at the same relative exercise intensity, whilst IL-6 
release was augmented when exercising at the same abso-
lute intensity. This is in agreement with the current study 
where there was no effect of hypoxia on post-exercise 
Table 1  Plasma cytokine concentrations before, immediately after and 2 h after exercise in normoxia and hypobaric hypoxia
Values are mean (95 % CI)
# Significantly different from pre-exercise (P < 0.01)
† Significantly different from post-exercise (P < 0.01)
PRE POST 2 h POST
IL-1a (pg/ml)
 Normoxia 0.30 (0.17–0.42) 0.25 (0.15–0.36) 0.26 (0.17–0.36)
 Hypoxia 0.29 (0.21–0.37) 0.31 (0.22–0.41) 0.37 (0.17–0.36)
IL-6 (pg/ml)
 Normoxia 0.70 (0.58–0.85) 2.71 (2.11–3.49)# 1.10 (0.85–1.44)#,†
 Hypoxia 0.70 (0.55–0.88) 2.53 (2.00–3.20)# 1.09 (0.83–1.41)#,†
IL-8 (pg/ml)
 Normoxia 2.26 (1.90–2.62) 3.47 (2.90–4.04)# 2.71 (2.10–3.33)†
 Hypoxia 2.19 (1.84–2.55) 3.31 (2.53–4.09)# 2.71 (2.01–3.40)†
IL-10 (pg/ml)
 Normoxia 1.10 (0.84–1.44) 1.50 (1.10–2.11) 1.10 (0.89–1.35)†
 Hypoxia 0.69 (0.39–1.16) 1.55 (1.12–2.21) 1.10 (0.82–1.49)†
TNFα (pg/ml)
 Normoxia 2.44 (1.99–2.88) 2.44 (2.09–2.80) 2.24 (1.86–2.62)
 Hypoxia 2.18 (1.88–2.48) 2.27 (1.99–2.55) 2.48 (1.98–2.48)
EGF (pg/ml)
 Normoxia 11.3 (8.9–14.0) 17.4 (12.1–23.8) 17.9 (13.5–22.9)
 Hypoxia 12.7 (8.9–17.2) 16.3 (10.1–23.9) 11.6 (7.2–16.9)
VEGF (pg/ml)
 Normoxia 14.7 (12.2–17.8) 11.5 (8.8–15.0)# 14.9 (11.5–19.3)†
 Hypoxia 13.3 (10.3–17.3) 12.0 (9.0–16.0)# 14.1 (11.4–17.4)†
MCP1 (pg/ml)
 Normoxia 107 (93–120) 124 (111–137)# 105 (93–117)†
 Hypoxia 103 (92–113) 121 (108–135)# 111 (94–127)†
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plasma concentrations of IL-6, or any of the other meas-
ured cytokines, when cycling at 70 % of altitude specific V˙
O2max. The 134 nmol/L difference in post-exercise cortisol 
was not of sufficient magnitude to influence cytokine pro-
duction and is unlikely to meaningfully impair host 
defence, particularly since this difference was no longer 
present following 2 h recovery.
It is well established that exercise causes changes in 
circulating lymphocytes subsets, including a transient 
decrease in CD4:CD8 ratio (Fry et al. 1992; Nieman 
et al. 1991). The results of the current study suggest 
that this exercise-induced decrease is more pronounced 
when exercising in hypobaric hypoxia, even when rela-
tive exercise intensity is the same. This was principally 
driven by a greater increase in circulating CD8+ cells 
in H, but also, although to a lesser extent, by an exac-
erbated post-exercise reduction in circulating CD4+ 
cells. The normal resting range for healthy individuals 
is 1.5–2.5, although this can vary considerably with age 
and genetics (Amadori et al. 1995). In four participants, 
exercise in hypoxia was associated with a post-exercise 
CD4:CD8 ratio of <1.0. Although the clinical relevance 
of this is not clear, CD4:CD8 ratio is an important 
marker of immune health. HIV (Fauci 1993) as well as a 
number of acute viral infections such as Influenza, cyto-
megalovirus and Epstein-Barr virus are typically associ-
ated with an inversion of the CD4:CD8 ratio (Gratama 
et al. 1986; Amadori et al. 1995). Although plasma cat-
echolamine concentrations were not measured in the 
current study, it is possible to speculate that the greater 
reduction in CD4:CD8 ratio observed in the hypoxic trial 
may have been due to higher levels of circulating adrena-
line. Compared to CD4+ cells, CD8+ lymphocytes have 
more β-adrenergic receptors (Landmann et al. 1984; Van 
Tits et al. 1990) which likely explains the greater mobi-
lization of CD8+ cells observed with exercise. Although 
only speculation, it has been previously shown that the 
catecholamine response in trained individuals is aug-
mented when exercising in hypoxia at the same absolute 
intensity (Kjaer et al. 1988), and to a lesser degree also 
at the same relative intensity (Kjaer et al. 1988). This is 
supported by the higher post-exercise cortisol observed 
in the hypoxic trial in the current study, since the mag-
nitude of the cortisol response typically reflects the mag-
nitude of the catecholamine response. It is worth not-
ing that there was no longer a significant difference in 
either plasma cortisol or CD4:CD8 ratio between trials 
2 h post-exercise. As such, any negative effects of acute 
hypoxic exercise on host defence appear to be short-
lived. Nevertheless, athletes utilising this training may 
benefit from taking some additional precautions to mini-
mise pathogens exposure during the 2 h window imme-
diately post-hypoxic exercise.
The observed reductions in TNF-α and IL-1 release in 
response to antigen challenge 2 h post-exercise in both tri-
als correspond with previous studies reporting a temporal 
Fig. 3  Pro-inflammatory cytokine production by whole blood cul-
ture in response to a multi-antigen challenge. IL-2 interleukin 2, IL-1 
interleukin 1 (α + β), IFNγ interferon gamma, TNFα tumour necrosis 
factor alpha. Data are mean ± SD. #Significant main effect of time 
for TNFα and IL-1 (P < 0.05)
Fig. 4  Anti-inflammatory cytokine production by whole blood cul-
ture in response to a multi-antigen challenge. IL-10 interleukin 10, 
IL-4 interleukin 4. Data are mean ± SD. #Significant main effect of 
time for IL-4 (P < 0.01)
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suppression of mitogen- or LPS-stimulated production of 
type 1 cytokines following prolonged exercise (Baum et al. 
1997; Drenth et al. 1995; Lewicki et al. 1988; Starkie et 
al. 2000). Conversely, while IL-4 production was also sig-
nificantly reduced, previous studies have found that acute 
endurance exercise has little or no effect on IL-4 release 
in response to mitogen stimulation (Lancaster et al. 2004, 
2005). However, in the current study these changes likely 
primarily reflect changes in the number of responder 
cells in the culture (i.e., changes in circulating leukocyte 
Table 2  Concentrations and secretion rates of salivary antimicrobial proteins before, immediately after and 2 h after exercise in normoxia and 
hypobaric hypoxia
Data are mean ± SD
# Significantly different from pre-exercise (P < 0.01)
† Significantly different from post-exercise (P < 0.01)
Table 3  Lymphocyte subsets before, immediately after and 2 h after exercise in normoxia (N) and hypobaric hypoxia (H)
Data are mean ± SD
# Significantly different from pre-exercise (P < 0.05)
† Significantly different from post-exercise (P < 0.05). n = 8
a Relative numbers of lymphocytes are presented as percentage of total leukocytes, while lymphocyte subsets are presented as percentage of 
total lymphocytes
Absolute (×109 cells/L) Relativea (% total leukocytes/lympho-
cytes)
PRE POST 2 h POST PRE POST 2 h POST
Lymphocytes N 1.54 ± 0.53 1.59 ± 0.51 1.30 ± 0.46† 32 ± 9 23 ± 6# 15 ± 7#,†
H 1.49 ± 0.47 1.75 ± 0.35 1.02 ± 0.27† 32 ± 9 23 ± 6# 12 ± 7#,†
T (CD3+) N 0.79 ± 0.28 0.74 ± 0.24 0.53 ± 0.16† 52 ± 10 48 ± 13 43 ± 15
H 0.75 ± 0.31 0.81 ± 0.31 0.52 ± 0.12† 50 ± 13 46 ± 12 52 ± 14
T helper (CD3+CD4+) N 0.46 ± 0.12 0.39 ± 0.10 0.32 ± 0.10#,† 30 ± 5 26 ± 6 27 ± 11
H 0.43 ± 0.15 0.39 ± 0.11 0.31 ± 0.06#,† 29 ± 8 23 ± 7 32 ± 9
T suppressor (CD3+CD8+) N 0.32 ± 0.18 0.32 ± 0.14 0.20 ± 0.08† 20 ± 8 20 ± 8 16 ± 4
H 0.30 ± 0.18 0.38 ± 0.22 0.20 ± 0.08† 19 ± 8 21 ± 9 19 ± 7
T regulatory (CD4+CD25+CD127−) N 0.03 ± 0.02 0.03 ± 0.02 0.02 ± 0.01 2.0 ± 0.6 1.7 ± 0.7 1.2 ± 0.5
H 0.03 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 2.0 ± 0.5 1.6 ± 0.8 1.8 ± 1.1
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subsets). This is a weakness of the method used, since it 
does not allow identification of which cells in the culture 
are producing specific cytokines. On the other hand, using 
viral and/or bacterial antigens to stimulate cytokine produc-
tion in whole blood culture probably most closely repre-
sents the natural environment, avoiding artefacts from cell 
isolation and preparation and enabling normal interactions 
between antigens and immune components within the nat-
ural hormonal milieu. Furthermore, it gives a measure of 
the total capacity to respond to an immune challenge at that 
specific time-point. The results of the current study indicate 
that the post-exercise reduction in cytokine production is 
not exacerbated when exercise of the same relative inten-
sity is performed in hypobaric hypoxia.
Tiollier et al. (2005) found no influence of living high 
and training low on salivary S-IgA. Pilardeau et al. (1990), 
meanwhile, found that saliva flow rate was significantly 
increased when exercising at 4350 masl compared to at 
sea level, while alpha-amylase concentration was unaf-
fected. However, we are not aware of any previous stud-
ies that have investigated the effects of acute exercise 
and hypoxia on salivary S-IgA, lysozyme and lactoferrin, 
which are postulated to play an important role in mucosal 
immunity and first-line defence against invading microbi-
als (Dürr et al. 2006; Fahlman and Engels 2005; Neville 
et al. 2008; Tenovuo 1989). Exercise-induced changes in 
salivary S-IgA and lactoferrin do not appear to be affected 
by moderate hypoxia when relative exercise intensity 
is the same. Lysozyme is a major antimicrobial protein 
in saliva and, as such, is an important component of the 
innate immune system. It displays a wide range of anti-
microbial activities, principally via cleaving of glycosidic 
bonds between the C-1 of N-acetylmuramic acid and the 
C-4 of N-acetylglucosamine in the peptidoglycan of the 
bacterial cell wall (Jollès and Jollès 1984). As such, a 
reduction in salivary lysozyme concentration/secretion has 
the potential to compromise host defence against bacterial 
pathogens. However, the significant trial effect observed 
for salivary lysozyme in our study can likely be largely 
explained by lower lysozyme concentration and secretion 
rate already at baseline in the hypoxic trial, rather than an 
effect of hypoxia. It is possible to speculate that the dif-
ference in salivary lysozyme concentration and secretion 
rate between H and N pre-exercise may have been due to 
an anticipatory effect, since participants were not blind 
to the condition. Walsh et al. (1999) found that salivary 
α-amylase secretion was reduced immediately pre-exer-
cise, and the authors speculated that this may have been 
due to anticipatory psychological stress. We are not aware 
of any studies that have examined whether such an antici-
patory effect is present for salivary lysozyme. However, 
Yang and colleagues (2002) have reported a negative cor-
relation between self-perceived work stress and salivary 
lysozyme secretion rate. Unfortunately, it was not possible 
to blind participants in the present study, since we were not 
able to reduce the barometric pressure inside the decom-
pression chamber without the participant noticing. Overall, 
the results of the current study do not indicate that cycling 
for 75 min at 70 % V˙O2max negatively influences mucosal 
immunity, regardless of whether exercise is performed in 
normoxia or hypobaric hypoxia. Indeed, both concentra-
tion and secretion rates of lysozyme and lactoferrin were 
increased post-exercise in both conditions. This corre-
sponds with previous studies that have reported similarly 
elevated concentrations of salivary lysozyme and lactofer-
rin following intense endurance exercise at sea level (All-
grove et al. 2008; West et al. 2010).
It should be noted that these results are not representative 
of the effects of a prolonged altitude sojourn, during which 
an athlete is continuously exposed to hypoxia, typically for 
several weeks. However, the exercise stimulus and hypoxic 
dose used in the current study are of high relevance to the 
increasing number of athletes who use “Live low, train high” 
protocols (McLean et al. 2014), since this type of hypoxic 
training involves performing a proportion of training ses-
sions in acute hypoxia, while otherwise residing at sea level.
Conclusion
Acute hypoxic exercise is associated with somewhat higher 
plasma cortisol and lower CD4:CD8 ratio immediately 
post-exercise. However, whether these differences are of 
Fig. 5  Exercise-induced change in CD4/CD8 ratio. Bars represent 
group mean, lines represent individual changes. *Significant differ-
ence from normoxia (P < 0.05)
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sufficient magnitude to meaningfully impair host defence 
is questionable, particularly since they appear transient in 
nature and since the other measured markers of immunity 
were unaffected. As such, athletes can likely implement 
“Live low, train high” regimes without notably increas-
ing their risk of infection, although a little additional care 
to minimise pathogen exposure during the 2 h window 
immediately post-hypoxic exercise may be pertinent. Fur-
thermore, since previous studies have shown that hypoxic 
exercise at the same absolute workload can significantly 
exacerbate immune disturbances, this highlights the impor-
tance of accurately adjusting and monitoring exercise 
intensity during hypoxic training.
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